---
- :identifier: C16564
  :notation: ETHNIC
  :preferred_term: Patient Ethnic Group
  :synonym: Ethnicity
  :extensible: true
  :definition: A social group characterized by a distinctive social and cultural tradition
    maintained from generation to generation, a common history and origin and a sense
    of identification with the group; members of the group have distinctive features
    in their way of life, shared experiences and often a common genetic heritage;
    these features may be reflected in their experience of health and disease. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzE2NTY0L1YxI0MxNjU2NA==
  :tags: SDTM
- :identifier: C16960
  :notation: Patient
  :preferred_term: Patient Ethnic Group
  :synonym: ''
  :extensible: true
  :definition: A person who receives medical attention, care, or treatment, or who
    is registered with medical professional or institution with the purpose to receive
    medical care when necessary. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzE2OTYwL1YxI0MxNjk2MA==
  :tags: SDTM
- :identifier: C20587
  :notation: AGESPAN
  :preferred_term: Age Group
  :synonym: Age Span
  :extensible: true
  :definition: Subgroups of populations based on age. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzIwNTg3L1YxI0MyMDU4Nw==
  :tags: SDTM
- :identifier: C25464
  :notation: COUNTRY
  :preferred_term: Country
  :synonym: Country
  :extensible: false
  :definition: A collective generic term that refers here to a wide variety of dependencies,
    areas of special sovereignty, uninhabited islands, and other entities in addition
    to the traditional countries or independent states. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzI1NDY0L1YxI0MyNTQ2NA==
  :tags: SDTM
- :identifier: C25681
  :notation: SIZE
  :preferred_term: Size
  :synonym: Size
  :extensible: true
  :definition: The physical magnitude of something. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzI1NjgxL1YxI0MyNTY4MQ==
  :tags: SDTM
- :identifier: C28421
  :notation: SEX
  :preferred_term: Sex
  :synonym: Sex
  :extensible: false
  :definition: The assemblage of physical properties or qualities by which male is
    distinguished from female; the physical difference between male and female; the
    distinguishing peculiarity of male or female. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzI4NDIxL1YxI0MyODQyMQ==
  :tags: SDTM
- :identifier: C38114
  :notation: ROUTE
  :preferred_term: Route of Administration
  :synonym: Route of Administration
  :extensible: true
  :definition: The course by which a substance was administered in order to reach
    the site of action in the body.
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzM4MTE0L1YxI0MzODExNA==
  :tags: SDTM
- :identifier: C42636
  :notation: FRM
  :preferred_term: Pharmaceutical Dosage Form
  :synonym: Dose Form
  :extensible: true
  :definition: The form of the completed pharmaceutical product, e.g. tablet, capsule,
    injection, elixir, suppository. Dosage form can have a significant effect on the
    onset, duration and intensity of the pharmacological action of a drug. A pharmaceutical
    dosage form controls the rate at which the drug is released into the biological
    fluids. This release rate affects its intrinsic absorption pattern and therefore,
    the bioavailability of the drug.
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQyNjM2L1YxI0M0MjYzNg==
  :tags: SDTM
- :identifier: C48281
  :notation: TPHASE
  :preferred_term: Trial Phase
  :synonym: Trial Phase
  :extensible: true
  :definition: 'Clinical trials are broken into three or four phases: Phase I tests
    a new drug or treatment for safety in a small group; Phase II expands the study
    to a larger group of people; Phase III expands the study to an even larger group
    of people to measure whether the treatment actually benefits patients, and whether
    its benefits exceed its risks; and Phase IV takes place after the drug or treatment
    has been licensed and marketed. (NCI)'
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ4MjgxL1YxI0M0ODI4MQ==
  :tags: SDTM
- :identifier: C49480
  :notation: IECAT
  :preferred_term: Category for Inclusion and or Exclusion
  :synonym: Category for Inclusion/Exclusion
  :extensible: false
  :definition: A collection of criteria on which subjects are evaluated and that must
    be met by all study subjects. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NDgwL1YxI0M0OTQ4MA==
  :tags: SDTM
- :identifier: C49484
  :notation: ND
  :preferred_term: Not Done
  :synonym: ND; Not Done
  :extensible: false
  :definition: Indicates a task, process or examination that has either not been initiated
    or completed. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NDg0L1YxI0M0OTQ4NA==
  :tags: SDTM
- :identifier: C49486
  :notation: NY
  :preferred_term: Yes, No, Unknown, or Not Applicable Response
  :synonym: No Yes Response
  :extensible: false
  :definition: A term that is used to indicate a question with permissible values
    of yes/no/unknown/not applicable.
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NDg2L1YxI0M0OTQ4Ng==
  :tags: SDTM
- :identifier: C49489
  :notation: OUT
  :preferred_term: Adverse Event Outcome
  :synonym: Outcome of Event
  :extensible: false
  :definition: A condition or event that is attributed to the adverse event and is
    the result or conclusion of the adverse event. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NDg5L1YxI0M0OTQ4OQ==
  :tags: SDTM
- :identifier: C49499
  :notation: ACN
  :preferred_term: Action Taken with Study Treatment
  :synonym: Action Taken with Study Treatment
  :extensible: false
  :definition: The reason that changes were made to the therapy under study. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NDk5L1YxI0M0OTQ5OQ==
  :tags: SDTM
- :identifier: C49558
  :notation: DOMAIN
  :preferred_term: Submission Domain Abbreviation
  :synonym: Domain Abbreviation
  :extensible: true
  :definition: A unique, 2-character domain code used in the regulatory submission
    process.  The domain abbreviation is used consistently throughout the submission,
    i.e. in the dataset name, as the value of the domain variable within the dataset,
    and as a prefix for most variable names in the dataset. (CDISC Glossary)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NTU4L1YxI0M0OTU1OA==
  :tags: SDTM
- :identifier: C49627
  :notation: NCOMPLT
  :preferred_term: Reason for Non-Completion
  :synonym: Completion/Reason for Non-Completion
  :extensible: true
  :definition: The reason that a subject was discontinued from a clinical trial.
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NjI3L1YxI0M0OTYyNw==
  :tags: SDTM
- :identifier: C49638
  :notation: STENRF
  :preferred_term: Relation to Reference Period
  :synonym: Relation to Reference Period
  :extensible: false
  :definition: The name of a code list that contains terms that reference timepoints
    within and without a defined time period.
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NjM4L1YxI0M0OTYzOA==
  :tags: SDTM
- :identifier: C49647
  :notation: TCNTRL
  :preferred_term: Control Type
  :synonym: Type of Control
  :extensible: true
  :definition: Comparator against which the study treatment is evaluated (e.g., concurrent
    (placebo, no treatment, dose-response, active), external (historical, published
    literature).
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NjQ3L1YxI0M0OTY0Nw==
  :tags: SDTM
- :identifier: C49650
  :notation: TDIGRP
  :preferred_term: Diagnosis Group
  :synonym: Diagnosis Group
  :extensible: true
  :definition: A grouping of individuals on the basis of a shared procedure or disease,
    or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with
    renal cell cancer).  Standardized naming systems are available that define the
    groups within which a subject should be placed. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NjUwL1YxI0M0OTY1MA==
  :tags: SDTM
- :identifier: C49652
  :notation: TINDTP
  :preferred_term: Trial Indication Type
  :synonym: Trial Indication Type
  :extensible: true
  :definition: The name of a code list that contains terms to define the type of trial,
    e.g. cure or prevention. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NjUyL1YxI0M0OTY1Mg==
  :tags: SDTM
- :identifier: C49658
  :notation: "[TBLIND]"
  :preferred_term: Trial Blinding Schema
  :synonym: Trial Blinding Schema
  :extensible: true
  :definition: The name of a code list that contains terms to define the type of blinding
    for the trial. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NjU4L1YxI0M0OTY1OA==
  :tags: SDTM
- :identifier: C49660
  :notation: TTYPE
  :preferred_term: Trial Type
  :synonym: Type of Trial
  :extensible: true
  :definition: The type of clinical trial performed e.g. efficacy, safety. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NjYwL1YxI0M0OTY2MA==
  :tags: SDTM
- :identifier: C49672
  :notation: VSTEST
  :preferred_term: Vital Signs
  :synonym: Vital Signs Test Name
  :extensible: true
  :definition: The name given to the test that analyzes a particular set of vital
    signs including temperature, respiratory rate, heart beat (pulse), and blood pressure.
    (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NjcyL1YxI0M0OTY3Mg==
  :tags: SDTM
- :identifier: C49675
  :notation: VSRESU
  :preferred_term: Units for Vital Signs Results
  :synonym: Units for Vital Signs Results
  :extensible: true
  :definition: The unit used to record and describe the result of a test investigating
    a vital sign. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5Njc1L1YxI0M0OTY3NQ==
  :tags: SDTM
- :identifier: C49691
  :notation: TSPARM
  :preferred_term: Trial Summary Parameter
  :synonym: Trial Summary Parameter
  :extensible: true
  :definition: Individual characteristics of a clinical trial, e.g. description of
    trial design, trial blinding schema, and primary objective of trial. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NjkxL1YxI0M0OTY5MQ==
  :tags: SDTM
- :identifier: C49696
  :notation: SEXPOP
  :preferred_term: Sex of Study Group
  :synonym: Sex of Participants
  :extensible: false
  :definition: The specific sex, either male, female, or mixed of the subject group
    being studied. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5Njk2L1YxI0M0OTY5Ng==
  :tags: SDTM
- :identifier: C49704
  :notation: TOXGR
  :preferred_term: Common Terminology Criteria for Adverse Events
  :synonym: Standard Toxicity Grade
  :extensible: false
  :definition: A standard terminology developed to report adverse events occurring
    in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE)
    are used in study adverse event summaries and Investigational New Drug reports
    to the Food and Drug Administration.  The CTCAE contain a grading scale for each
    adverse event term representing the severity of the event. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NzA0L1YxI0M0OTcwNA==
  :tags: SDTM
- :identifier: C49705
  :notation: AESEV
  :preferred_term: Severity/Intensity Scale for Adverse Events
  :synonym: Severity/Intensity of an Adverse Event
  :extensible: false
  :definition: A scale that defines the degree or state of disease existing in a patient
    as a result of the occurrence of an adverse event. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzQ5NzA1L1YxI0M0OTcwNQ==
  :tags: SDTM
- :identifier: C50399
  :notation: DICTNAM
  :preferred_term: Dictionary Name
  :synonym: Name of Dictionary
  :extensible: true
  :definition: A name given to a reference source that lists words and gives their
    meaning. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzUwMzk5L1YxI0M1MDM5OQ==
  :tags: SDTM
- :identifier: C50400
  :notation: AGEU
  :preferred_term: Age Unit
  :synonym: Age Units
  :extensible: false
  :definition: Those units of time that are routinely used to express the age of a
    person. (NCI)
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzUwNDAwL1YxI0M1MDQwMA==
  :tags: SDTM
- :identifier: C64388
  :notation: SOC
  :preferred_term: CDISC System Organ Class
  :synonym: System Organ Class
  :extensible: false
  :definition: Terms at the highest level of the CDISC system organ class terminology.
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzY0Mzg4L1YxI0M2NDM4OA==
  :tags: SDTM
- :identifier: C65047
  :notation: LABTEST
  :preferred_term: CDISC SDTM Laboratory Test Terminology
  :synonym: ''
  :extensible: true
  :definition: Terminology used for Laboratory Tests of the CDISC Standard Data Tabulation
    Model.
  :id: aHR0cDovL3d3dy5jZGlzYy5vcmcvQzY1MDQ3L1YxI0M2NTA0Nw==
  :tags: SDTM
